Clinical Trials
Blood Cells Generated In Lab Transfused Into First Patients
In the first clinical trial of its sort, lab-grown blood cells were administered to a second patient, potentially paving the way for future therapies for blood disorders like sickle cell.
At the NHS Blood and Transplant (NHSBT) Advanced Therapies Unit...
News
India Wants More Access To The UK Pharma Market- Official
As a part of the proposed free trade deal with Britain, India is looking at expanding access to markets for its pharmaceutical products in the UK, an official said on November 4. The official added that a leaked chapter...
Clinical Trials
First Simulated Drug Study Examines 2 Alzheimer Treatments
The effectiveness of aducanumab and donanemab in treating Alzheimer's disease (AD) was successfully simulated using a novel computer model, demonstrating how a steady rise in dosage until reaching the maximum dose helps to minimize cognitive loss and limit adverse...
News
Global Pharma Morale On A New High
Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which were released at this year's CPhI Frankfurt. This bodes well for the industry's prospects in...
News
Good Laboratory Practices: Why They’re Important and how to Implement Them
Good laboratory practices are important because they keep labs from misinterpreting their results and prevent contamination. As such, GLPs are especially important when dealing with living organisms or cells, which can spread disease and cause other forms of infection...
Drug Research
$2mn In The US, Gene Therapies Might Become The Standard
In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird Bio was forced to pull its blood disorder medicine Zynteglo from the European market after...
News
U.S. Cancer Medicine Pricing Increases 53% In Five Years
According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of a newly-launched cancer medicine in the United States was $283,000 last year, a 53% rise...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.